These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 85057)

  • 21. Serum immunoreactive trypsin in cystic fibrosis.
    Burlina A; Rizzotti P; Tonon M; Mastella G
    Scand J Gastroenterol Suppl; 1980; 62():35-43. PubMed ID: 6935754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mucoviscidosis screening by determination of immunoreactive trypsin].
    Sander J; Niehaus C
    Klin Padiatr; 1984; 196(4):224-7. PubMed ID: 6482307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neonatal screening for cystic fibrosis in the Trent region (UK): two-stage immunoreactive trypsin screening compared with a three-stage protocol with DNA analysis as an intermediate step.
    Pollitt RJ; Dalton A; Evans S; Hughes HN; Curtis D
    J Med Screen; 1997; 4(1):23-8. PubMed ID: 9200059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of radioimmunoassay for serum trypsin in cystic fibrosis.
    Blitzer MG; Shapira E
    J Pediatr Gastroenterol Nutr; 1982; 1(3):289-90. PubMed ID: 7186041
    [No Abstract]   [Full Text] [Related]  

  • 25. [Levels of immunoreactive trypsin in the serum in children].
    Tomásová H; Vávrová V; Dvorák P; Zizkovský V; Strajer J
    Cesk Pediatr; 1983 Sep; 38(9):537-9. PubMed ID: 6640755
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunoreactive trypsin in the serum of normal children and children with gastrointestinal diseases].
    Dockter G; Steyns M; Biro G; Sitzmann FC
    Monatsschr Kinderheilkd; 1984 Aug; 132(8):589-93. PubMed ID: 6482880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-competitive enzyme immunoassay of human trypsin 1.
    Carrere J; Grataroli R; Marfin J; Ferrua B; Thouvenot JP; Figarella C
    J Immunol Methods; 1983 May; 60(1-2):235-42. PubMed ID: 6343497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of 4 neonatal screening strategies for cystic fibrosis.
    van den Akker-van Marle ME; Dankert HM; Verkerk PH; Dankert-Roelse JE
    Pediatrics; 2006 Sep; 118(3):896-905. PubMed ID: 16950979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newborn screening for cystic fibrosis using an enzyme linked immunoabsorbent assay (ELISA) technique.
    Bowling FG; Brown AR
    Clin Chim Acta; 1988 Feb; 171(2-3):257-61. PubMed ID: 3370824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Systematic neonatal screening for mucoviscidosis using an immunoreactive trypsin blood assay. Evaluation of 80,000 tests].
    Travert G; Duhamel JF
    Arch Fr Pediatr; 1983 Apr; 40(4):295-8. PubMed ID: 6882116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conclusions from a pilot immunoreactive trypsin newborn screen for cystic fibrosis.
    Kirby LT; Davidson AG; Applegarth DA; Wong LT; Hardwick DF
    Clin Chem; 1983 Aug; 29(8):1559-60. PubMed ID: 6872228
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum immunoreactive trypsin in cystic fibrosis.
    Dandona P; Hodson M; Bell J; Ramdial L; Beldon I; Batten JC
    Thorax; 1981 Jan; 36(1):60-2. PubMed ID: 7292384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The international quality assurance program (IRTIQAS) for the assay of immunoreactive trypsin in dried blood spots.
    Heeley ME; Travert G; Ferre C; Lemonnier F
    Pediatr Pulmonol Suppl; 1991; 7():72-5. PubMed ID: 1782136
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunoreactive trypsin levels in neonates with meconium ileus.
    Steven LC; Gavel G; Young D; Carachi R
    Pediatr Surg Int; 2006 Mar; 22(3):236-9. PubMed ID: 16395608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dried blood spot immunoreactive trypsin (IRT) values.
    Pederzini F; Mastella G; Giglio L; Faraguna D
    Eur J Pediatr; 1988 Aug; 147(6):663. PubMed ID: 3181210
    [No Abstract]   [Full Text] [Related]  

  • 36. [Screening of newborn infants for cystic fibrosis. A combined analysis of immunoreactive trypsin and delta F508 mutation--a screening without false positive results].
    Nørgaard-Pedersen B; Høgdall EV; Arends J; Vuust J
    Ugeskr Laeger; 1994 Jun; 156(25):3757-60. PubMed ID: 8059453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neonatal screening for cystic fibrosis in Wales and the West Midlands: 1. Evaluation of immunoreactive trypsin test.
    Ryley HC; Deam SM; Williams J; Alfaham M; Weller PH; Goodchild MC; Carter RA; Bradley D; Dodge JA
    J Clin Pathol; 1988 Jul; 41(7):726-9. PubMed ID: 3410967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trisomy 18, cystic fibrosis, and blood immunoreactive trypsin.
    Heeley AF; Fagan DG
    Lancet; 1984 Jan; 1(8369):169-70. PubMed ID: 6140482
    [No Abstract]   [Full Text] [Related]  

  • 39. [Mucoviscidosis screening with immunoreactive trypsin. Initial experiences in Austria].
    Eber E; Zach M; Engele H; Haas J; Pürstner P; Mutz I; Litscher H
    Monatsschr Kinderheilkd; 1992 Jul; 140(7):411-5. PubMed ID: 1501616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased immunoreactive trypsin levels in sera from cystic fibrosis patients.
    Duffy MJ; McGarry Y; Hynes N; Duffy GJ; Tobin MJ; Fitzgerald MX
    Clin Chim Acta; 1980 Apr; 103(2):233-5. PubMed ID: 7371202
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.